Bard PowerPort Catheter Lawsuit

Published By:
Jessie Paluch
Jessie Paluch

Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.

This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.

TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.

Key takeaways:

  • The Bard PowerPort implantable device is linked to severe complications such as catheter fractures, infections, thrombotic events, and device migration, leading to a Class 2 recall and ongoing safety concerns.
  • Design flaws in the Bard PowerPort catheter, particularly material degradation and structural issues, compromise patient safety over time.
  • Patients face severe long-term health consequences, including chronic pain and recurring infections, prompting numerous lawsuits for compensation.

Overview of the Bard PowerPort Catheter Lawsuit

The Bard PowerPort catheter lawsuit have been at the center of numerous claims regarding design and manufacturing defects.

This medical device, intended for the intravenous delivery of fluids and medications, has been reported to experience issues primarily due to the material properties of its Chronoflex catheter tubing, which is susceptible to fissuring and fracturing.

On this page, we’ll provide an overview of the Bard PowerPort Catheter Lawsuit, Bard PowerPort complications reported nationwide, studies on Bard PowerPort medical device defects, and much more.

Bard PowerPort Catheter Lawsuit

Legal Experts Investigate Common Injuries: Bard PowerPort Catheter Lawsuit

The Bard PowerPort implanted device has been associated with these severe complications, leading to numerous legal actions against Bard Access Systems for prioritizing profits over patient safety.

As a result, there is ongoing multidistrict Bard PowerPort litigation focusing on these allegations, with claims still in the early investigation and litigation stages.

Common injuries noted in lawsuits related to the Bard PowerPort typically include:

  • Catheter fractures and migration
  • Bloodstream infections and embolisms
  • Deep vein thrombosis
  • Cardiac issues like arrhythmias
  • Internal bleeding and perforation
  • Other serious health conditions

These injuries not only pose immediate health risks but can also require additional medical interventions or surgeries, increasing the burden on patients.

If you or someone you love has experienced serious complications after receiving a Bard PowerPort catheter, you may be eligible to seek compensation.

Contact TruLaw using the chat on this page to receive an instant case evaluation that can determine your eligibility to join others filing in the Bard PowerPort MDL today.

Table of Contents

Studies on Bard PowerPort Medical Device Defects

The research documented in FDA adverse event reports and NIH-published studies has revealed significant concerns about the Bard PowerPort catheter device’s safety profile.

Multiple reports in the FDA’s MAUDE database and clinical studies have documented issues with device performance and patient outcomes.

Patients affected by the defective Bard PowerPort device may claim damages for severe injuries, including malfunction, migration, and life-threatening complications.

Medical Research and Testing Conducted

Clinical studies tracked through the FDA’s medical device reporting system have identified several areas of concern with the implantable port catheter device, specifically the PowerPort’s design and performance.

According to FDA documentation, the device underwent a Class 2 recall, indicating potential temporary or medically reversible health consequences.

Key findings from government sources include:

  • FDA MAUDE database documentation of device failures
  • NIH studies on implanted port complications
  • Clinical data on post-implantation outcomes
  • FDA adverse event reporting patterns

These research findings have been instrumental in establishing patterns of device failure and identifying potential safety concerns.

Government documentation through the MAUDE database has provided a systematic record of adverse events, while NIH studies have offered detailed analyses of complications and outcomes.

This body of evidence has become increasingly important as healthcare providers and patients seek to understand the risks associated with PowerPort devices.

Types of Injuries in the Bard PowerPort MDL

The FDA’s MAUDE database and NIH research on implanted ports have documented numerous adverse events associated with PowerPort devices.

These reports detail complications ranging from minor issues to severe medical emergencies requiring immediate intervention.

Government sources such as the FDA MAUDE database confirm these primary complications:

  • Catheter-related complications: Including catheter fracture, pinch-off syndrome where the catheter is compressed between the clavicle and first rib, catheter disconnection from the port body, and catheter tip malposition
  • Port system failures: Including port reservoir rupture, septum dysfunction preventing proper needle access, internal blockage requiring thrombolytic therapy, and port inversion or rotation
  • Infection risks: Including port pocket infections, catheter-related bloodstream infections (CRBSI), tunnel infections along the catheter tract, and systemic infections leading to sepsis
  • Thrombotic events: Including catheter-associated thrombosis, deep vein thrombosis (DVT), superior vena cava syndrome, and fibrin sheath formation around the catheter
  • Device migration incidents: Including port chamber displacement, catheter tip migration into other vessels, extravasation of infused medications, and complete device dislodgement requiring surgical removal

The severity and frequency of these complications have led to significant concerns within the medical community.

According to NIH research, many of these complications require additional surgical interventions and extended hospital stays.

The documented pattern of device-related injuries has contributed to growing scrutiny of the PowerPort system’s safety profile and has become central to ongoing litigation efforts.

Design Flaws in the Bard PowerPort Catheter

The research documented in NIH material analysis studies has revealed significant design and structural issues with the Bard implanted port catheter system.

Multiple scientific investigations have identified specific material vulnerabilities that may contribute to device failure and patient complications.

The Bard PowerPort, a port catheter device primarily used for chemotherapy treatments, has been the subject of ongoing lawsuits alleging design and manufacturing flaws, which can lead to severe complications for patients, including fractures, migration, and other serious injuries.

Issues with the Catheter Materials and Usage

Laboratory studies of medical device materials have identified several critical concerns with the PowerPort’s design and composition.

The integration of barium sulfate with polyurethane materials has been particularly scrutinized for potential safety implications.

Material concerns documented in government studies include:

  • Structural degradation of polyurethane components
  • Compromised material integrity during extended use
  • Surface irregularities from barium sulfate interaction
  • Interface failures between different materials
  • Chemical breakdown of core components

These material issues, documented through extensive NIH research, demonstrate significant concerns about the long-term stability of the device.

Laboratory analysis has shown that the combination of materials used in the PowerPort may create inherent weaknesses that develop over time, potentially compromising patient safety and device functionality.

Bard PowerPort Catheter Failure Patterns

Government studies on catheter complications have identified consistent patterns of device failure that raise serious concerns about Bard’s design integrity.

These patterns emerge from both laboratory testing and clinical observation.

Documented failure patterns include:

  • Progressive material degradation
  • Catheter fracture and faction
  • Component separation at stress points
  • Surface deterioration and irregularities
  • Structural integrity compromise

The frequency and consistency of these failure patterns, as documented in long-term performance studies, suggest fundamental issues with the device’s design and material composition.

Research indicates that these failures often develop gradually, making them particularly concerning for long-term implant patients who rely on the device for critical medical treatment.

Bard PowerPort Complications Reported Nationwide

Government research on implantable ports has documented numerous complications associated with Bard PowerPorts, including infections and blood clots.

Certain Bard PowerPort devices have been linked to serious injuries and defects, leading to ongoing multidistrict litigation and highlighting the importance of legal support for affected patients.

These adverse events range from immediate post-implantation issues to serious long-term medical complications that often require additional surgical intervention.

Categories of Bard PowerPort-Related Injuries

Clinical studies of port complications have identified distinct categories of device-related injuries that affect patient health and safety, including those associated with Bard Peripheral Vascular devices.

These complications often require immediate medical attention and can lead to serious health consequences.

Documented categories of injuries include:

  1. Immediate post-implantation complications: Including surgical site infections, hematoma formation, pneumothorax, and improper device positioning requiring immediate revision surgery
  2. Infection-related complications: Including localized port pocket infections, catheter-related bloodstream infections (CRBSI), and sepsis requiring device removal and extensive antibiotic treatment
  3. Mechanical device failures: Including catheter fracture, port separation, catheter occlusion, and material degradation leading to device malfunction
  4. Vascular system injuries: Including deep vein thrombosis, venous stenosis, catheter migration causing vessel perforation, and embolism
  5. Tissue and organ damage: Including tissue necrosis around the port site, cardiac tamponade from catheter perforation, and erosion through surrounding tissues

According to extensive research on port-related complications, these injuries often develop in patterns that suggest systemic issues with the device’s design and functionality.

The frequency and severity of these complications have raised significant concerns about patient safety and the need for enhanced monitoring protocols.

Long-Term Health Consequences for Affected Patients

Long-term studies of patient outcomes reveal significant ongoing health impacts for individuals affected by PowerPort complications.

These consequences often extend well beyond the initial device failure or complication.

Documented long-term consequences include:

  • Chronic pain and discomfort
  • Recurring infections
  • Permanent vascular damage
  • Extended rehabilitation needs
  • Ongoing medical monitoring requirements

The impact of these long-term health consequences, as documented in NIH research on port complications, demonstrates the significant burden placed on affected patients.

Studies indicate that many patients require ongoing medical care and face lasting impacts on their quality of life, often necessitating substantial changes to their healthcare management strategies.

TruLaw: Your Bard PowerPort Catheter Law Firm

Bard PowerPort catheter lawsuits are being filed by individuals across the country who were injured due to defective Bard PowerPort devices.

Consulting experienced Bard PowerPort lawyers is crucial for navigating the complexities of product liability claims and increasing the chances of securing compensation.

Potential plaintiffs can file a Bard PowerPort lawsuit by understanding the eligibility criteria and the legal support available to help secure financial compensation.

TruLaw is currently accepting clients for the Bard PowerPort catheter lawsuit.

A few reasons to choose TruLaw for your Bard PowerPort catheter lawsuit include:

  • If We Don’t Win, You Don’t Pay: The medical device lawyers at TruLaw and our partner firms operate on a contingency fee basis, meaning we only get paid if you win.
  • Expertise: We have years of experience handling medical device cases similar to the Bard PowerPort catheter lawsuit, which helps us anticipate what we can expect to see in your case and the regulations we will be required to meet.
  • Successful Track Record: TruLaw and our partner law firms have helped our clients recover billions of dollars in compensation through verdicts and negotiated settlements.

If you or a loved one suffered injuries related to a defective Bard PowerPort catheter, you may be eligible to seek compensation.

Contact TruLaw using the chat on this page to receive an instant case evaluation that can determine if you qualify for the Bard PowerPort catheter lawsuit today.

Frequently Asked Questions

  • What is the Bard PowerPort catheter lawsuit about?

    The Bard PowerPort catheter lawsuit involves allegations of design and manufacturing defects in devices used for intravenous delivery of fluids and medications.

    The lawsuits claim that Bard failed to warn users about potential hazards and didn’t address design flaws in the Chronoflex catheter tubing that is prone to fissuring and fracturing.

    The Bard PowerPort multidistrict litigation consolidates these claims, detailing processes like the completion of Plaintiff Fact Sheets, updates on the litigation’s progress, and ongoing court deliberations.

  • What are the common injuries associated with defective Bard PowerPort catheters?

    Common injuries associated with the PowerPort implantable port include catheter fractures, bloodstream infections, deep vein thrombosis, cardiac arrhythmias, and internal bleeding.

    These complications often require additional medical interventions or surgeries and can lead to severe health consequences.

  • What evidence supports the Bard PowerPort catheter lawsuits?

    Multiple reports in the FDA’s MAUDE database and NIH-published studies have documented significant safety concerns and device failures.

    The evidence includes clinical studies, adverse event reports, and a Bard PowerPort recall indicating potential temporary or medically reversible health consequences.

  • What design flaws have been identified in the Bard PowerPort catheter?

    Laboratory studies have identified issues with the integration of barium sulfate with polyurethane materials and the structural degradation of components.

    Research shows that the combination of materials creates inherent weaknesses that develop over time, compromising device functionality and patient safety.

  • What are the long-term health consequences for patients with defective Bard PowerPort catheters?

    Patients often experience chronic pain, recurring infections, permanent vascular damage, and ongoing medical monitoring requirements.

    These long-term impacts significantly affect quality of life and typically require substantial changes to healthcare management strategies.

  • How can affected patients seek compensation through TruLaw?

    TruLaw operates on a contingency fee basis and offers expertise in handling medical device cases similar to the Bard PowerPort catheter lawsuit.

    Affected individuals can receive an instant case evaluation through TruLaw’s chat feature to determine their eligibility for compensation.

Published By:
Jessie Paluch
Jessie Paluch

Experienced Attorney & Legal SaaS CEO

With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three.  She spent the first decade of her career working as an international tax attorney at Deloitte.

In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.

In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!

AFFF Lawsuit

AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.

Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.

Suboxone Lawsuit

Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.

Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.

Social Media Lawsuits

Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.

Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.

Vaginal Mesh Lawsuits

Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).

Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.

Bair Hugger Lawsuit

Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).

Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.

Baby Formula NEC Lawsuit

Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.

Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.

Do You
Have A Case?

Here, at TruLaw, we’re committed to helping victims get the justice they deserve.

Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Helpful Sites & Resources